Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
82
AGYS Quote, Financials, Valuation and Earnings
Last price:
$109.69
Seasonality move
:
4.79%
Day range:
$108.94 - $111.77
52-week range:
$63.71 - $142.64
Dividend yield:
0%
P/E ratio:
132.12x
P/S ratio:
11.24x
P/B ratio:
11.56x
Volume:
304.2K
Avg. volume:
316.5K
1-year change:
18.63%
Market cap:
$3.1B
Revenue:
$275.6M
EPS (TTM):
$0.83
Analysts' Opinion
-
Consensus RatingAgilysys has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $118.40, Agilysys has an estimated upside of 7.97% from its current price of $109.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $90.00 representing 17.93% downside risk from its current price of $109.66.
Fair Value
-
According to the consensus of 5 analysts, Agilysys has 7.97% upside to fair value with a price target of $118.40 per share.
AGYS vs. S&P 500
-
Over the past 5 trading days, Agilysys has overperformed the S&P 500 by 2.57% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Agilysys does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Agilysys has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Agilysys reported revenues of $74.3M.
Earnings Growth
-
Agilysys has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Agilysys reported earnings per share of $0.14.
Enterprise value:
3B
EV / Invested capital:
10.43x
Price / LTM sales:
11.24x
EV / EBIT:
117.17x
EV / Revenue:
10.97x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
57.76x
Price / Operating cash flow:
59.17x
Enterprise value / EBITDA:
89.44x
Gross Profit (TTM):
$172M
Return On Assets:
5.73%
Net Income Margin (TTM):
8.43%
Return On Equity:
9.12%
Return On Invested Capital:
8.38%
Operating Margin:
7.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $198.1M | $237.5M | $275.6M | $62.2M | $74.3M | |
| Gross Profit | $120.8M | $144.3M | $172M | $38.3M | $45.1M | |
| Operating Income | $13.2M | $15.8M | $23.4M | $3.5M | $5.5M | |
| EBITDA | $20.3M | $25.2M | $33.8M | $6.1M | $8.3M | |
| Diluted EPS | $0.49 | $3.16 | $0.83 | $0.11 | $0.14 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $133.3M | $136.2M | $154.7M | $188.9M | $123.5M | |
| Total Assets | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Current Liabilities | $61.2M | $71.5M | $78.5M | $89.4M | $111M | |
| Total Liabilities | $74.5M | $81.4M | $98.3M | $114M | $168.5M | |
| Total Equity | $115.3M | $132.8M | $144.8M | $236.5M | $265.9M | |
| Total Debt | -- | -- | -- | -- | $24M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $34.5M | $48.2M | $55.1M | $29.8M | $27.2M | |
| Cash From Investing | -$6.9M | -$7.6M | -$148.6M | $58K | -$1.5M | |
| Cash From Financing | -$11.1M | -$8.6M | $21.9M | -$1.2M | -$13.3M | |
| Free Cash Flow | $27.2M | $40.1M | $52.3M | $29.3M | $26.5M | |
AGYS
Sector
Market Cap
$3.1B
$80.5M
Price % of 52-Week High
76.88%
62.62%
Dividend Yield
0%
0%
Shareholder Yield
-0.1%
0.79%
1-Year Price Total Return
18.63%
-12.71%
Beta (5-Year)
0.737
0.820
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$106.80
200-day SMA
Buy
Level
$101.85
Bollinger Bands (100)
Buy
Level
69.03 - 103.53
Chaikin Money Flow
Buy
Level
7M
20-day SMA
Buy
Level
$95.05
Relative Strength Index (RSI14)
Buy
Level
77.35
ADX Line
Buy
Level
55.06
Williams %R
Sell
Level
-7.1121
50-day SMA
Buy
Level
$81.31
MACD (12, 26)
Buy
Level
8.71
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
47.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.6315)
Buy
CA Score
(Annual)
Level (0.7659)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.2567)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.
Stock Forecast FAQ
In the current month, AGYS has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AGYS average analyst price target in the past 3 months is $118.40.
-
Where Will Agilysys Stock Be In 1 Year?
According to analysts, the consensus estimate is that Agilysys share price will rise to $118.40 per share over the next 12 months.
-
What Do Analysts Say About Agilysys?
Analysts are divided on their view about Agilysys share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agilysys is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is Agilysys's Price Target?
The price target for Agilysys over the next 1-year time period is forecast to be $118.40 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AGYS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Agilysys is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AGYS?
You can purchase shares of Agilysys via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agilysys shares.
-
What Is The Agilysys Share Price Today?
Agilysys was last trading at $109.69 per share. This represents the most recent stock quote for Agilysys. Yesterday, Agilysys closed at $109.66 per share.
-
How To Buy Agilysys Stock Online?
In order to purchase Agilysys stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
52
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
